Evaluation of the Fracture Liaison Service within the Canadian Healthcare Setting.
Journal
Journal of osteoporosis
ISSN: 2090-8059
Titre abrégé: J Osteoporos
Pays: United States
ID NLM: 101538878
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
05
2019
accepted:
17
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
Previous studies evaluating fracture liaison service (FLS) programs have found them to be cost-effective, efficient, and reduce the risk of fracture. However, few studies have evaluated the clinical effectiveness of these programs. We compared the patient populations of those referred for osteoporosis management by FLS to those referred by primary care physicians (PCP), within the Canadian healthcare system in the province of Ontario. Specifically, we investigated if a referral from FLS is similarly effective as PCP at identifying patients at risk for future osteoporotic fractures and if osteoporosis therapies have been previously initiated. A retrospective chart review of patients assessed by a single Ontario rheumatology practice affiliated with FLS between January 1, 2014, and December 31, 2017, was performed identifying two groups: those referred by FLS within Hamilton and those referred by their PCP for osteoporosis management. Fracture risk of each patient was determined using FRAX. A total of 573 patients (
Identifiants
pubmed: 32257097
doi: 10.1155/2020/6742604
pmc: PMC7115141
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6742604Informations de copyright
Copyright © 2020 Matthew Wong-Pack et al.
Déclaration de conflit d'intérêts
A.N. Lau has received consulting fee (less than $10,000 each), speaking fee, and/or honoraria from Amgen Inc., Abbvie, Bristol Meyers Squibb, Roche, and UCB Pharma. J.D. Adachi has received consulting fee (less than $10,000 each), speaking fee, and/or honoraria from AgNovos, Amgen Inc., Eli Lilly, and Merck. M. Wong-Pack, N. Naqvi, and G. Ioannidis have no conflicts of interest to declare.
Références
Osteoporos Int. 2013 Feb;24(2):393-406
pubmed: 22829395
JAMA. 2009 Feb 4;301(5):513-21
pubmed: 19190316
J Bone Joint Surg Am. 2017 May 17;99(10):820-831
pubmed: 28509822
Best Pract Res Clin Rheumatol. 2006 Aug;20(4):695-706
pubmed: 16979533
Bone. 2018 Jun;111:92-100
pubmed: 29555309
J Bone Joint Surg Am. 2015 Apr 15;97(8):675-81
pubmed: 25878314
Osteoporos Int. 2018 Feb;29(2):397-407
pubmed: 29170857
Osteoporos Int. 2011 Jul;22(7):2051-65
pubmed: 21607807
CMAJ. 2010 Nov 23;182(17):1864-73
pubmed: 20940232
Osteoporos Int. 2011 Jul;22(7):2067-82
pubmed: 21607808
Osteoporos Int. 2008 Apr;19(4):385-97
pubmed: 18292978
Osteoporos Int. 2018 Jun;29(6):1227-1242
pubmed: 29460102
Osteoporos Int. 2016 Oct;27(10):3023-32
pubmed: 27166680